VeriMomethinylestradiol hamilelikte güvenli mi?
Ethinylestradiol (CAS 57-63-6) has a harmonised CLP classification as Repr. 1B (H360—may damage fertility or the unborn child) per ECHA, which meets the criterion for h=3. It is a potent synthetic estrogen with demonstrated estrogen receptor agonism and animal data showing adverse effects on fetal growth/survival, supporting m=2. For topical cosmetic use, systemic exposure from a cosmetic formulation would be negligible/very low, so e=0 (noting ethinylestradiol is primarily used as an oral/vaginal pharmaceutical rather than a cosmetic). ([echa.europa.eu](https://echa.europa.eu/brief-profile/-/briefprofile/100.014.129?utm_source=openai))
Hamilelikte ethinylestradiol yerine kullanılabilecek güvenli alternatifler | VeriMom
Related ingredients
Frequently asked questions
- ethinylestradiol hamilelikte güvenli mi?
- Ethinylestradiol (CAS 57-63-6) has a harmonised CLP classification as Repr. 1B (H360—may damage fertility or the unborn child) per ECHA, which meets the criterion for h=3. It is a potent synthetic estrogen with demonstrated estrogen receptor agonism and animal data showing adverse effects on fetal growth/survival, supporting m=2. For topical cosmetic use, systemic exposure from a cosmetic formulation would be negligible/very low, so e=0 (noting ethinylestradiol is primarily used as an oral/vaginal pharmaceutical rather than a cosmetic). ([echa.europa.eu](https://echa.europa.eu/brief-profile/-/briefprofile/100.014.129?utm_source=openai))
- ethinylestradiol emzirirken güvenli mi?
- Harmonised classification H360 (Repr. 1B) equally flags lactation-related reproductive hazard (h=3). Mechanistically, ethinylestradiol is an estrogen receptor agonist with demonstrated endocrine activity (m=2). Human studies indicate transfer into breast milk is negligible with low‑dose combined hormonal contraceptives, so exposure via milk from typical systemic use is low but measurable (e=1); for topical cosmetic use systemic uptake would be expected to be very low. ([echa.europa.eu](https://echa.europa.eu/brief-profile/-/briefprofile/100.014.129?utm_source=openai))
- ethinylestradiol bebek cildi için güvenli mi?
- Hazard (H360 Repr. 1B) remains (h=3). Mechanistic evidence of estrogenic activity supports m=2. For topical cosmetic use adult dermal exposure is expected to be negligible (adult e=0); per the scoring rules, baby skin exposure is increased by +1 (e=1) because infant skin is more permeable — although ethinylestradiol is not a typical cosmetic ingredient and meaningful topical cosmetic exposure is unlikely. Animal studies show prenatal/placental effects but no infant‑specific dermal data were found. ([echa.europa.eu](https://echa.europa.eu/brief-profile/-/briefprofile/100.014.129?utm_source=openai))
- VeriMom ethinylestradiol nasıl puanlıyor?
- VeriMom ethinylestradiol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 27/100 (yüksek risk) olarak puanlar.
- Hamilelikte ethinylestradiol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.